Several cancer types, including GC, are associated with immunosuppression.26,27 Several studies have reported an association between the levels of immunosuppressive markers and GC progression.28–30 In the present study, we evaluated the levels of immunosuppressive markers (PD-L1 and IL-10) in the peripheral blood and tumor tissues of GC patients. This evidence concerns the gene IL10 and gastric cancer.